[1] SWERDLOW S H, Campo E, Harris N L, et al. WHO classification of tumors of haematopoietic and lymphoid tissues[M]. 4th.Lyon: IARC, 2008: 150.
[2] RAGHAVACHAR A, BARTRAM C R, GANSER A, et al. Acute undifferentiated leukemia: implications for cellular origin and clonality suggested by analysis of surface markers and immunoglobulin gene rearrangement[J]. Blood, 1986, 68(3): 658-662.
[3] 张之南, 郝玉书, 赵永强, 等. 血液病学[M]. 2版. 北京: 人民卫生出版社, 2011: 743-744.
[4] 袁芳芳, 魏旭东, 尹青松, 等. 急性未分化型白血病二例[J]. 中华血液学杂志, 2013, 34(7): 625.
[5] 张前鹏, 韩永胜, 皖湘. 急性未分化白血病2例并文献复习[J]. 安徽医药, 2016, 20(2): 350-351.
[6] VON LINDERN M, VAN BAAL S, WIEGANT J, et al. Can, a purative oncogene associated with myeloid leukemogenesis, may be activated by fusion of its 3’ half to different genes: Characterization of the set gene[J]. Mol cell Biol,1992, 12(8): 3346-3355.
[7] ADACHI Y, PAVLAKIS G N, COPELAND T D. Identification and characterization of SET, a nuclear phosphoprotein encoded by the translocation break point in acute undiffer-entiated leukemia[J]. Biol Chem, 1994, 269(3): 2258-2262.
[8] CERVONI N, DETICH N, SEO S B, et al. The oncoprotein Set/TAF-1 beta, an inhibitor of histone acetyhransferase, inhibits active demethylation of DNA, integrating DNA methylation and transcriptional silencing[J]. J Biol Chem, 2002, 277(28): 25026-25031.
[9] VERONIKA P, SAJAD K, GIORGI B, et al. 5-Azacitidine monotherapy followed by related haploidentical hematopoietic stem cell transplantation achieves durable remission in a pediatric patient with acute undifferentiatedleukemia refractory to high-dose chemotherapy[J]. Pediatr Blood Cancer, 2016, 63(6): 1111-1112.